Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04890613
Title Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Senhwa Biosciences, Inc.

ovarian cancer

pancreatic cancer

prostate cancer

breast cancer

fallopian tube cancer

Advanced Solid Tumor

peritoneum cancer



Age Groups: senior | adult
Covered Countries USA | CAN

No variant requirements are available.